Big Pharma Selling Blood Pressure Meds With Compound In Kratom

This is the first in a series of posts breaking down the alkaloids found in kratom that nobody ever talks about. The entire public conversation about this plant focuses on two compounds — mitragynine and 7-hydroxymitragynine. There are over 40. Some of them are being actively researched. Some are already in pharmaceutical products. And none of them get mentioned when legislators vote to ban the plant.

That needs to change. And the only way it changes is data.

Meet Ajmalicine

Ajmalicine is an alkaloid naturally present in plain leaf kratom. It's also known as δ-yohimbine or raubasine, and if those names don't ring a bell, maybe these will: Cristanyl, Lamuran, Duxil, Sarpan.

Those are brand names. Pharmaceutical brand names. For a drug used to treat high blood pressure and circulatory disorders.

Ajmalicine is an antihypertensive medication already in clinical use — and the molecule is present in all plain leaf kratom.

Where Do Pharmaceutical Companies Get It?

They don't extract it from kratom. They source it primarily from Madagascar periwinkle (Catharanthus roseus) and Indian snakeroot (Rauwolfia serpentina), a plant that has been used in Ayurvedic medicine for centuries. It's also found in cat's claw (Uncaria tomentosa), which is sold in most supplement stores and widely studied for its anti-inflammatory and neuroprotective properties.

Pharmaceutical companies extract an estimated 3,500 kilograms of ajmalicine from natural plant sources every single year for therapeutic use in the treatment of circulatory diseases.

The same molecule. Already being isolated at industrial scale. Already sold under multiple brand names. Also naturally present in plain leaf kratom — where it makes up a small but real portion of the total alkaloid content.

Why Does This Matter?

Because the entire regulatory and public debate about kratom treats it as if it contains two things — mitragynine and 7-OH — and nothing else. Every legislative hearing, every FDA statement, every DEA review focuses exclusively on those two compounds.

Meanwhile the plant contains ajmalicine, which is already a pharmaceutical product. It contains epicatechin, the same antioxidant found in dark chocolate and green tea. It contains rhynchophylline, the same compound that gives cat's claw its neuroprotective reputation. It contains corynoxeine, which has been studied in cellular models for Parkinson's disease. It also has many many more.

When a legislator votes to ban plain leaf kratom, they are voting to ban a plant containing compounds that are:

• Already sold as pharmaceutical drugs
• Already sold as supplements in every health food store
• Already being researched for neurodegenerative diseases
• Already found in foods like dark chocolate, green tea, and apples

They just don't know that. Because the data doesn't exist in a form that makes it into a hearing room.

The Research Gap Nobody Is Talking About

The most cited kratom study in existence surveyed 8,049 users in 2017 — once, from memory. That's the foundation lawmakers are working from when they make decisions about a plant used by an estimated 5 million Americans.

No real-time data. No longitudinal tracking. No compound-specific outcome data. Nothing that connects what's actually in the plant to what people actually experience when they use it.

That's the gap. And it's the gap that allows legislators to treat plain leaf kratom the same as a concentrated 7-OH gas station product, because there's nothing to show them the difference in human terms.

What Log & Taper It Is Building

Log & Taper It is a kratom tracking app building the largest real-time kratom dataset ever collected. Users log their doses, strains, vendors, and effects anonymously — creating a continuous, real-world picture of what plain leaf kratom actually does to people at real doses.

It's not a study. It's a dataset. And researchers can use datasets to run studies. Policymakers can reference datasets in hearings. Lawyers can cite datasets in regulatory challenges.

But only if the dataset exists.

Every dose logged is a data point that didn't exist before. Every strain entry, every effect tag, every vendor record — all of it building toward something that no one has ever had access to in this space.

If you use kratom and you want your experience to count toward something — this is how.

Download the app and join the dataset at ilivetruth.com/join

If you're a vendor and want your products represented in the data — ilivetruth.com/vendors

This is the first post in an ongoing series covering the alkaloids in kratom that regulators, researchers, and the public have largely ignored. Next up: epicatechin — the same antioxidant in your dark chocolate, also in every gram of kratom.